Biochemical and cellular toxicology of peroxynitrite: Implications in cell death and autoimmune phenomenon

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 3, 2009, Pages 388-396

  Ahmad, Rizwan ^a   Rasheed, Zafar ^a   Ahsan, Haseeb ^b  

^a Sardar Bhagwan Singh Post Gratudate Institute of Biomedical Sciences & Research   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Autoimmunity; Cytotoxicity; Immunotoxicology; Nitric Oxide; Peroxynitrite

Indexed keywords

AUTOANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITROGEN DIOXIDE; PEROXYNITRITE; SUPEROXIDE;

APOPTOSIS; CELL DEATH; CYTOTOXICITY; DIABETES MELLITUS; DNA DAMAGE; DNA STRAND BREAKAGE; HUMAN; INFLAMMATORY DISEASE; MACROMOLECULE; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTE; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; REVIEW; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS; DNA DAMAGE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEOPLASMS; OXIDANTS; OXIDATION-REDUCTION; PEROXYNITROUS ACID; STRESS, PHYSIOLOGICAL; STROKE;

EID: 70350689746     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970802709197     Document Type: Review

References (103)

1. Szabo, C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. (2003); 140-141: 105-112.
2. Pacher, P., Beckman, JS., Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. (2007); 87(1): 315-424.
3. Szabo, C., Ischiropoulos, H., Radi, R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov. (2007); 6(8): 662-680
4. Squadrito, GL., Pryor, WA. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Rad Biol Med. (1998); 25(4-5): 392-403.
5. Ahsan, H., Ali, A., Ali, R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol. (2003); 131(3): 398-404.
6. Waris, G., Ahsan, H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog. (2006); 5:14.
7. Pryor, WA., Squadrito, GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol. (1995); 268(5 pt 1): L699-L722.
8. Radi, R., Peluffo, G., Alvarez, MN., Naviliat, M., Cayota, A.Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med. (2001); 30(5): 463-488
9. Beckman, JS., Chen, J., Ischiropoulos, H., Crow JP. Oxidative chemistry of peroxynitrite. Methods Enzymol. (1994); 233: 229-240
10. Koppenol, WH., Moreno, JJ., Pryor, WA., Ischiropoulos, H., Beckman, JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol. (1992); 5(6): 834-842
11. Uppu, R.M., Pryor, WA. Synthesis of peroxynitrite in a twophase system using isoamyl nitrite and hydrogen peroxide. Anal Biochem. (1996); 236(2): 242-249.
12. Dixit, K., Moinuddin Ali, A. Immunological studies on peroxynitrite modified DNA. Life Sci. (2005); 77(21): 2626-2642
13. Habib, S., MoinuddinAli, R. Peroxynitrite-modified DNA: a better antigen for systemic lupus erythematosus anti-DNA autoantibodies. Biotechnol Appl Biochem. (2006); 43(2), 65-70.
14. Robinson, KM., Beckman, JS. Synthesis of peroxynitrite from nitrite and hydrogen peroxide. Methods Enzymol. (2005); 396: 207-214.
15. Forstermann, U., Munzel, T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. (2006); 113(13): 1708-1714
16. Romero, N., Denicola, A., Radi, R. Red blood cells in the metabolism of nitric oxide-derived peroxynitrite. IUBMB Life. (2006); 58(10): 572-580
17. Ahmad, R., Rasheed Z, Kaushal, E., Singh, D., Ahsan, H. Biochemical evaluation of human DNA-lysine photoadduct treated with peroxynitrite. Toxicol Mech Meth. (2008); 18(7): 589-595.
18. Maeda, H., Akaike, T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc). (1998); 63(7): 854-865.
19. Ohshima, H., Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res. (1994); 305(2): 253-264.
20. Rubbo, H. Nitric oxide and peroxynitrite in lipid peroxidation. Medicina (B Aires). (1998); 58(4), 361-366. (Pubitemid 128519201)
21. Rubbo, H., Freeman, BA. Nitric oxide regulation of lipid oxidation reactions: formation and analysis of nitrogen-containing oxidized lipid derivatives. Methods Enzymol. (1996); 269: 385-394.
22. Rubbo, H., Radi, R., Trujillo, M., Telleri, R., Kalyanaraman, B., Barnes, S., Kirk, M., Freeman, B. A., Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem. (1994); 269(42): 26066-26075.
23. Ramezanian, MS., Padmaja, S., Koppenol, WH. Nitration and hydroxylation of phenolic compounds by Peroxynitrite. Chem Res Toxicol. (1996); 9(1): 232-240. (Pubitemid 26041291)
24. Ramezanian, MS., Padmaja, S., Koppenol, W.H. Nitration and hydroxylation of phenolic compounds by Peroxynitrite. Methods Enzymol. (1996); 269: 195-201. (Pubitemid 26295708)
25. Alvarez, B., Radi, R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids. (2003); 25(3-4): 295-311.
26. Luxford, C., Morin, B., Dean, R.T., Davies, M.J. Histone H1 and other protein- and amino acid-hydroperoxides can give rise to free radicals which oxidize DNA. Biochem J. (1999); 344(1), 125-134.
27. Douki, T., Cadet, J. Peroxynitrite mediated oxidation of purine bases of nucleosides and isolated DNA. Free Rad Res. (1996); 24(5): 369-380.
28. Douki, T., Cadet, J., Ames, B.N. An adduct between peroxynitrite and 2'-deoxyguanosine: 4,5-dihydro-5-hydroxy-4-(nitrosooxy)- 2'-deoxyguanosine. Chem Res Toixcol. (1996); 9(1): 3-7.
29. Wiseman, H., Halliwell, B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J. (1996); 313(1): 17-29.
30. Ohshima, H., Virág, L., Souza, J., Yermilov, V., Pignatelli, B., Masuda, M., Szabo, C. Detection of certain peroxynitrite-induced DNA modifications. Methods Mol Biol. (2002); 186: 77-88.
31. Szabo, C., Ohshima, H. DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide. (1997); 1(7): 373-385.
32. Tretyakova, N.Y., Burney, S., Pamir, B., Wishnok, J.S., Dedon, P.C., Wogan, G.N., Tannenbaum, S.R. Peroxynitrite-induced DNA damage in the sup F gene: correlation with the mutational spectrum. Mutat Res, (2000); 447(2): 287-303.
33. Ames, B.N., Shigenaga, M.K., Gold, L.S. DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis. Environ Health Perspect. (1993); 101(suppl 5): 35-44.
34. Ames, B.N., Shigenaga, M.K., Hagen, T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci (USA). (1993); 90(17): 7915-7922.
35. Sawa, T., Ohshima, H. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide. (2006); 14(2): 91-100.
36. Yermilov, V., Rubio, J., Becchi, M., Friesen, M.D., Pignatelli, B., Ohshima, H. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis. (1995); 16(9): 2045-2050.
37. Ohshima, H. Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicol Lett. (2003); 140-141: 99-104.
38. Suzuki, T., Mower, H.F., Friesen, M.D., Gilibert, I., Sawa, T., Ohshima, H. Nitration and nitrosation of N-acetyl-L-tryptophan and tryptophan residues in proteins by various reactive nitrogen species. Free Rad Biol Med. (2004); 37(5): 671-681.
39. Beckman, J.S., Koppenol, W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. (1996); 271(5 Pt 1): C1424-1437.
40. Beckman, J.S. Oxidative damage and tyrosine nitration from Peroxynitrite. Chem Res Toxicol. (1996); 9(5): 836-844.
41. Beckman, J.S. Protein tyrosine nitration and peroxynitrite. FASEB J. (2002); 16(9): 1144.
42. Greenacre, S.A., Ischiropoulos, H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Rad Res. (2001); 34(6): 541-581.
43. Ischiropoulos, H., Zhu, L., Chen, J., Tsai, M., Martin. J.C., Smith, C.D., Beckman, J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophy. (1992); 298(2): 431-437.
44. Hausladen, A., Fridovich, I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem. (1994); 269(47): 29405-29408.
45. Mihm, M.J., Yu, F., Carnes, C.A., Reiser, P.J., McCarthy, P.M., Van Wagoner, D.R., Bauer, J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. (2001); 104(2): 174-180.
46. Grune, T., Blasig, I.E., Sitte, N., Roloff, B., Haseloff. R., Davies, K.J. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J Biol Chem. (1998); 273(18): 10857-10862.
47. Aykac-Toker, G., Bulgurcuoglu, S., Kocak-Toker, N. Effect of peroxynitrite on glutaredoxin. Hum Exp Toxicol. (2001); 20(7): 373-376.
48. Cuzzocrea, S., Zingarelli, B., O'Connor, M., Salzman, A.L., Szabo, C. Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma- glutamylcysteine synthetase on peroxynitrite and endotoxic shock-induced vascular failure. Br J Pharmacol. (1998); 123(3): 525-537.
49. Van der Vliet, A., Smith, D., O'Neill, C.A., Kaur, H., Darley- Usmar, V., Cross, C.E., Halliwell, B. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J. (1994); 303(1): 295-301.
50. Klebl, B.M., Ayoub, A.T., Pette, D. Protein oxidation, tyrosine nitration, and inactivation of sacroplasmic reticulum Ca2+- ATPase in low frequency stimulated rabbit muscle. FEBS Lett. (1998); 422(3): 381-384.
51. Kerry, N., Rice-Evans, C. Peroxynitrite oxidizes catechols to o-quinones. FEBS Lett. (1998); 437(3): 167-171.
52. Goldstein, S., Czapski, G. Reactivity of Peroxynitrite versus simultaneous generation of (*)NO and O(2)(*)(-) towards NADH. Chem Res Toxicol. (2000); 13(8): 736-741.
53. deRojas-Walker, T., Tamir, S., Ji, H., Wishnok, J.S., Tannenbaum, S.R. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem Res Toxicol. (1995); 8(3): 473-477.
54. Jagtap, P., Szabo, C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov. (2005); 4(5): 421-440 (Pubitemid 40704125)
55. Virag, L., Szabo, C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev; 54(3): 375-429.
56. Szabo, C., Pacher, P., Swanson, R.A. Novel modulators of poly(ADP- ribose) polymerase. Trends Pharmacol Sci. (2006); 27(12): 626-630
57. Szabo, C. Poly(ADP-ribose) polymerase activation by reactive nitrogen species - relevance for the pathogenesis of inflammation. Nitric Oxide (2006); 14(2): 169-179.
58. Pacher, P., Szabo, C. Cardiovasc Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Drug Rev. (2007); 25(3): 235-260
59. Szabo, C., Salzman, A.L., Ischiropoulos, H. Peroxynitritemediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemiareperfusion injury. FEBS Lett. (1995); 372(2-3): 229-232
60. Szabo, G., Bahrle, S., Stumpf, N., Sonnenberg, K., Szabo, E.E., Pacher, P., Csont, T., Schulz, R., Dengler, T.J., Liaudet, L., Jagtap, P.G., Southan, G.J., Vahl, C.F., Hagl, S., Szabo, C. Poly(ADPRibose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res. (2002); 90(1): 100-106
61. Szabo, C., Dawson, V.L. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci. (1998); 19(7): 287-298
62. Zingarelli, B., Salzman, A.L., Szabo, C. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/ reperfusion injury. Circ Res. (1998); 83(1): 85-94. (Pubitemid 28322102)
63. Szabo, C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock. (1996); 6(2): 79-88.
64. Thiemermann, C. Development of novel, water-soluble inhibitors of poly (adenosine 5'-diphosphate ribose) synthetase activity for use in shock and ischemia-reperfusion injury. Crit Care Med. (2002); 30(5): 1163-1165
65. Pacher, P., Cziraki, A., Mabley, J.G., Liaudet, L., Papp, L., Szabo, C. Biochem Pharmacol. (2002)Dec 15; 64(12): 1785-1791 Role of poly(ADP-ribose) polymerase activation in endotoxininduced cardiac collapse in rodents.
66. Pacher, P., Liaudet, L., Bai, P., Virag, L., Mabley, J.G., Hasko, G., Szabo, C. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J Pharmacol Exp Ther. (2002); 300(3): 862-867 (Pubitemid 34164989)
67. Pacher, P., Liaudet, L., Mabley. J., Komjati, K., Szabo, C. Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J Am Coll Cardiol. (2002); 40(5): 1006-1016
68. Pacher, P., Liaudet, L., Soriano, F.G., Mabley, J.G., Szabo, E., Szabo, C. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes. (2002); 51(2): 514-521 (Pubitemid 34764811)
69. Pacher, P., Liaudet, L., Bai, P., Mabley, J.G., Kaminski, P.M., Virag, L., Deb, A., Szabo, E., Ungvari, Z., Wolin, M.S., Groves, J.T., Szabo, C. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation. (2003); 107(6): 896-904.
70. Pacher, P., Vaslin, A., Benko, R., Mabley, J.G., Liaudet, L., Hasko, G., Marton, A., Batkai, S., Kollai, M., Szabo, C. A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp Ther. (2004); 311(2): 485-491
71. Pacher, P., Schulz, R., Liaudet, L., Szabo, C. Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci. (2005); 26(6): 302-310
72. Ungvari, Z., Gupte, S.A., Recchia, F.A., Batkai, S., Pacher, P. Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol. (2005); 3(3): 221-229
73. Pacher. P., Szabo, C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol. (2006); 6(2): 136-141 (Pubitemid 43362126)
74. Evgenov, O.V., Liaudet, L. Role of nitrosative stress and activation of poly (ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock. Curr Vasc Pharmacol. (2005); 3(3): 293-299
75. Jagtap, P., Soriano, F.G., Virag, L., Liaudet, L., Mabley, J., Szabo, E., Hasko, G., Marton, A., Lorigados, C.B., Gallyas, F.Jr., Sumegi, B., Hoyt, D.G., Baloglu, E., Van Duzer, J., Salzman, A.L., Southan, G.J., Szabo, C. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med. (2002); 30(5): 1071-1082
76. Soriano, F.G., Liaudet, L., Szabo, E., Virag, L., Mabley, J.G., Pacher, P., Szabo, C. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock. (2002); 17(4): 286-292
77. Liaudet, L., Soriano, F.G., Szabo, E., Virag, L., Mabley, J.G., Salzman, A.L., Szabo, C. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci U S A. (2000); 97(18): 10203-10208
78. Cuzzocrea S. Shock, inflammation and PARP. Pharmacol Res. (2005); 52(1): 72-82.
79. Pacher, P., Obrosova, I.G., Mabley, J.G., Szabó, C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications.Emerging new therapeutical strategies. Curr Med Chem. (2005); 12(3): 267-275
80. Szabo, C., Mabley, J.G., Moeller, S.M., Shimanovich, R., Pacher, P., Virag, L., Soriano, F.G., Van Duzer, J.H., Williams,W., Salzman, A.L., Groves, J.T. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med. (2002); 8(10): 571-580
81. Szabo, C., Zanchi, A., Komjati, K., Pacher, P., Krolewski, A.S., Quist, W.C., LoGerfo, F.W., Horton, E.S., Veves, A. Poly (ADPRibose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation. (2002); 106(21): 2680-2686
82. Obrosova, I.G., Li, F., Abatan, O.I., Forsell, M.A., Komjáti, K., Pacher, P., Szabó, C., Stevens, M.J. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes. (2004); 53(3): 711-720
83. Ilnytska, O., Lyzogubov, V.V., Stevens, M.J., Drel, V.R., Mashtalir, N., Pacher. P., Yorek, M.A., Obrosova, I.G. Poly(ADPribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes. (2006); 55(6): 1686-1694
84. Soriano, F.G., Virag, L., Jagtap, P., Szabo, E., Mabley, J.G., Liaudet, L., Marton, A., Hoyt, D.G., Murthy, K.G., Salzman, A.L., Southan, G.J., Szabo, C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med. (2001); 7(1): 108-113
85. Soriano, F.G., Pacher, P., Mabley, J., Liaudet, L., Szabo, C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res. (2001); 89(8): 684-691 (Pubitemid 34627068)
86. Liu, Z., Martin, L.J. Motor neurons rapidly accumulate DNA single-strand breaks after in vitro exposure to nitric oxide and peroxnitrite and in vivo axotomy. J Comp Neurol. (2001); 432(1): 35-60.
87. Whiteman, M., Armstrong, J.S., Cheung, N.S., Siau, J.L., Rose, P., Schantz, J.T., Jones, D.P., Halliwell, B. Peroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains. FASEB J. (2004); 18(12): 1395-1397
88. Radi, R., Cassina, A., Hodara, R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem. (2002); 383(3-4): 401-409
89. Klotz, L.O., Schroeder, P., Sies, H. Peroxynitrite signaling: receptor tyrosine kinases and activation of stress-responsive pathways. Free Rad Biol Med. (2002); 33(6): 737-743.
90. Cantoni, O., Tommasini, I., Cerioni, L., Palomba, L., Carloni, E., Guidarelli, A. Survival pathways triggered by peroxynitrite in cells belonging to the monocyte/macrophage lineage. Comp Biochem Physiol A Mol Integr Physiol. (2005); 142(2): 118-123.
91. Liaudet, L., Soriano, F.G., Szabo, C. Biology of nitric oxide signaling. Crit Care Med. (2000); 28(4 Suppl): N37-52.
92. Cantoni, O., Palomba, L., Guidarelli, A., Tommasini, I., Cerioni, L., Sestili, P. Cell signaling and cytotoxicity by peroxynitrite. Environ Health Perspect. (2002); 110 (Suppl 5): 823-825
93. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., Lipton, SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. (1995); 92(16): 7162-7166
94. Leist, M., Fava, E., Montecucco, C., Nicotera, P. Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur J Neurosci. (1997); 9(7): 1488-1498
95. Leist, M., Volbracht, C., Kühnle, S., Fava, E., Ferrando- May, E., Nicotera, P. Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol Med. (1997); 3(11): 750-764
96. Zhang, Y., Wang, H., Li, J., Jimenez, D.A., Levitan, E.S., Aizenman, E., Rosenberg, P.A. Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation. J Neurosci. (2004); 24(47): 10616-10627
97. Shacka, JJ., Sahawneh, M.A., Gonzalez, J.D., Ye, Y.Z., D'Alessandro, T.L., Estevez, A.G. Two distinct signaling pathways regulate peroxynitrite-induced apoptosis in PC12 cells. Cell Death Differ. (2006); 13(9): 1506-1514
98. Dickhout, J.G., Hossain, G.S., Pozza, L.M., Zhou, J., Lhotak, S., Austin, R.C. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler Thromb Vasc Biol. (2005); 25(12): 2623-2629
99. Burney, S., Caulfield, J.L., Niles, J.C., Wishnok, J.S., Tannenbaum, S.R. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res. (1999); 424(1-2): 37-49. (Pubitemid 29101606)
100. Habib, S., Moinuddin Ali, R. Acquired antigenicity of DNA after modification with peroxynitrite. Int J Biol Macromol. (2005); 35(3-4): 221-225
101. Habib, S., Moinuddin, Ali, A., Ali, R. Preferential recognition of peroxynitrite modified human DNA by circulating autoantibodies in cancer patients. Cell Immunol. (2008)
102. Wanchu, A., Khullar, M., Deodhar, S.D., Bambery, P., Sud, A. Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol Int. (1998); 18(2): 41-43
103. Oates, J.C., Ruiz, P., Alexander, A., Pippen, A.M., Gilkeson, G.S. Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol. (1997); 83(1): 86-92.